Neuland Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
17,666.00
381 (2.2%)
BSENSE

May 08

BSE+NSE Vol: 94.81 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "17,666.00",
    "chg": 381,
    "chgp": "2.2%",
    "dir": 1,
    "prev_price": "17,285.00",
    "mcapval": "22,386.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE794A01010",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "94.81 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Ltd Upgraded to Hold as Technicals Improve Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-upgraded-to-hold-as-technicals-improve-despite-financial-challenges-3977070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_mojoScore_3977070.png",
        "date": "2026-05-06 08:07:02",
        "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook and institutional backing despite recent financial headwinds. The upgrade is driven primarily by improved technical indicators, stable quality metrics, and a cautious valuation stance amid mixed financial trends."
      },
      {
        "title": "Neuland Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3976724",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_technicaldot_3976724.png",
        "date": "2026-05-06 08:00:38",
        "description": "Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism among investors as the stock navigates current market conditions."
      },
      {
        "title": "Neuland Laboratories Ltd Sees Technical Momentum Shift Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-sees-technical-momentum-shift-amid-strong-price-rally-3974628",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_technicaldot_3974628.png",
        "date": "2026-05-05 08:00:58",
        "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a strong day change of 7.58%, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum indicators suggesting cautious optimism for investors."
      },
      {
        "title": "Neuland Laboratories Ltd Surges 7.09% to Day's High of Rs 16,460 — Outperforms Sector by 5.81 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-709-surge-on-4-may-2026-3974037",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_priceRelatedfactors_3974037.png",
        "date": "2026-05-04 11:45:48",
        "description": "The Sensex advanced 0.99% on 4 May 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.09% gain, reaching an intraday high of Rs 16,460. This 5.81-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-sell-3968028",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_mojoScore_3968028.png",
        "date": "2026-04-29 10:10:53",
        "description": "Neuland Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-sell-3951916",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_mojoScore_3951916.png",
        "date": "2026-04-18 10:10:38",
        "description": "Neuland Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Neuland Laboratories Gains 13.03%: 4 Key Factors Driving This Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-gains-1303-4-key-factors-driving-this-weeks-rally-3943591",
        "imagepath": "",
        "date": "2026-04-12 13:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Intraday high of Rs.13,464 with 7.15% surge</p>\n                    <p><strong>7 Apr:</strong> Mojo Score upgraded to Sell from Strong Sell</p>\n                    <p><strong>8 Apr:</strong> Intraday high of Rs.14,077.3 with 7.33% surge</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.14,948.95, up 13.03%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.13,225.55</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.14,948.95</div><div class=\"stat-chan..."
      },
      {
        "title": "Neuland Laboratories Ltd Surges 7.33% to Day's High of Rs 14077.3 — Outperforms Sector by 6.06 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-733-surge-on-8-april-2026-3938006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_priceRelatedfactors_3938006.png",
        "date": "2026-04-08 15:30:44",
        "description": "The Sensex advanced 4.03% on 8 Apr 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.33% gain, reaching an intraday high of Rs 14,077.3. This 6.06-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind."
      },
      {
        "title": "Neuland Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3935682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_mojoScore_3935682.png",
        "date": "2026-04-07 08:10:32",
        "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift driven primarily by technical indicators, even as fundamental financial metrics continue to pose concerns. The company’s recent performance across quality, valuation, financial trends, and technicals has prompted analysts to revise their outlook, balancing cautious optimism with persistent challenges in profitability and growth."
      }
    ],
    "total": 759,
    "sid": "229993",
    "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "details": "Neuland Laboratories Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update- Change in name of Registrar & Share Transfer Agent of the Company.",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Registrar & Share Transfer Agent Update",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Neuland Laboratories Limited has submitted to the Exchange a copy of half yearly disclosure on Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Other General Purpose",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "Neuland Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Press Release\".",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Press Release",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Neuland Laboratories Limited - Registrar & Share Transfer Agent Update

09-Dec-2019 | Source : NSE

Neuland Laboratories Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update- Change in name of Registrar & Share Transfer Agent of the Company.

Neuland Laboratories Limited - Other General Purpose

27-Nov-2019 | Source : NSE

Neuland Laboratories Limited has submitted to the Exchange a copy of half yearly disclosure on Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Neuland Laboratories Limited - Press Release

15-Nov-2019 | Source : NSE

Neuland Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled "Press Release".

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

12 May 2026

stock-summary
DIVIDEND

Neuland Laboratories Ltd has declared 120% dividend, ex-date: 18 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Neuland Laboratories Ltd has announced 4:25 rights issue, ex-date: 13 Aug 14